1-20 of 1,594 results for subject:Misuse
Librarians' tools
- Search time
- 0.275 seconds
- Solr query time
- 0.016 seconds
- Search query
- subject:Misuse
- We searched for
- subject_t:Misuse OR subject_t:"Substance misuse" OR subject_ses:92056
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
In 2024, 76% of adults in England said that they drink alcohol. 21% of adults drank more than the recommended weekly limit of 14 units of alcohol.
In 2024, 76% of adults in England said that they drink alcohol. 21% of adults drank more than the recommended weekly limit of 14 units of alcohol.
To ask His Majesty's Government what assessment they have made of the role of digital technologies in supporting treatment and recovery services for people experiencing drug and alcohol addiction.
To ask His Majesty's Government what assessment they have made of the role of digital technologies in supporting treatment and recovery services for people experiencing drug and alcohol addiction.
The Government is continuing to invest in improvements to local alcohol and drug treatment services to ensure those in need can access high quality help and support. From 2026, all drug and alcohol treatment and recovery funding will be channelled through the Public Health Grant, with over £13.45 billion allocated across three years, including £3.4 billion ringfenced for drug and alcohol treatment and recovery.
Local authorities are responsible for assessing local needs for alcohol and drug prevention and treatment in their area, and commissioning services to meet these needs. The Government works with local treatment systems to provide a number of digital products including guidance, subject-matter expertise and data tools to help them deliver their service.
Digital products are derived from The National Drug Treatment Monitoring System and other related health datasets and made available via a dedicated website to enable local treatment systems to monitor treatment access and better manage outcomes.
To ask the Secretary of State for Health and Social Care, if his Department will review the Mental Health Act 1983 to ensure people with co-occurring mental health and substance misuse needs are not excluded from treatment.
To ask the Secretary of State for Health and Social Care, if his Department will review the Mental Health Act 1983 to ensure people with co-occurring mental health and substance misuse needs are not excluded from treatment.
The Mental Health Act 2025 will give patients greater choice, enhanced rights and support, and ensure everyone is treated with dignity and respect throughout treatment.
We know that people with co-occurring substance use and mental health needs do not always receive the integrated, person-centred care they require and deserve. We are committed to promoting more cohesion between mental health services and substance use services, to ensure people, included those subject to the Mental Health Act, no longer fall through the gaps of treatment. The Department and NHS England have published the Co-occurring Mental Health and Substance Use Delivery framework, which provides national commitments and calls to the sector on how the health system can improve delivery of integrated, person-centred care across drug and alcohol treatment and mental health services.
In developing this plan, we have worked with subject matter experts, including people with lived experience, academics, clinicians, and service providers, to set out a path to improving service provision for those with co-occurring substance use and mental health needs. This standard provides guidance for drug and alcohol treatment commissioners on improving services for people with co-occurring mental health and alcohol or drug conditions and how local services need to work together so that people can access the help they need.
To ask the Secretary of State for Health and Social Care, whether he has made an assessment with the Home Secretary of the potential merits of funding a wider rollout of long-acting Injectable Buprenorphine as a treatment option for people using opioids in Dorset.
To ask the Secretary of State for Health and Social Care, whether he has made an assessment with the Home Secretary of the potential merits of funding a wider rollout of long-acting Injectable Buprenorphine as a treatment option for people using opioids in Dorset.
The Department supports the provision of long-acting injectable buprenorphine as an option for those undergoing Opioid Substitution Treatment. Local authorities are responsible for commissioning drug and alcohol treatment services according to local need, and this includes the provision of long-acting injectable buprenorphine.
In addition to the Public Health Grant, in 2025/26 the Department is providing Dorset Council with £1,469,140 to improve drug and alcohol treatment and recovery services. The Department encourages local authorities to prioritise resourcing long-acting injectable buprenorphine prescribing from this additional funding if current provision is not adequate.
The Department is currently doing more analysis to understand cost-effectiveness and develop clinical guidance, and to scope out how best to expand access to long-acting injectable buprenorphine further.
A Commons debate on obesity and fatty liver disease will take place on Tuesday 28 October 2025. The debate will be opened by Dr Beccy Cooper. The Library will publish a briefing ahead of the debate.
A Commons debate on obesity and fatty liver disease will take place on Tuesday 28 October 2025. The debate will be opened by Dr Beccy Cooper. The Library will publish a briefing ahead of the debate.
On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.
On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.
The Controlled Drugs (Procedure for Specification) Bill 2024-2025 had its second reading on Friday 7 March 2025. It was considered by a Public Bill Committee on 25 June 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
The Controlled Drugs (Procedure for Specification) Bill 2024-2025 had its second reading on Friday 7 March 2025. It was considered by a Public Bill Committee on 25 June 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
A debate has been scheduled in Westminster Hall at 1.30pm on 27 March on prevention of drugs deaths. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.
A debate has been scheduled in Westminster Hall at 1.30pm on 27 March on prevention of drugs deaths. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.
Current UK legislation to control drugs, the enforcement of drug laws and calls for reform to the classification of drugs in the UK.
Current UK legislation to control drugs, the enforcement of drug laws and calls for reform to the classification of drugs in the UK.
Motion that the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved. Agreed to on question.
Motion that the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved. Agreed to on question.
It is not often that one speaks in this place on changes to the law that will have the direct result of saving lives, but once the draft regulations pass, as I hope they will this evening, we expect them to save many peoples’ lives. Today is a very special...
It is not often that one speaks in this place on changes to the law that will have the direct result of saving lives, but once the draft regulations pass, as I hope they will this evening, we expect them to save many peoples’ lives. Today is a very special...
It is good to a hear consensus building across the House on naloxone because, as we have heard from other Members, it is a lifesaver. Since its roll-out in the UK, that highly effective antidote to opioid intoxication has doubtlessly saved hundreds of lives and prevented many more harmful overdoses,...
It is good to a hear consensus building across the House on naloxone because, as we have heard from other Members, it is a lifesaver. Since its roll-out in the UK, that highly effective antidote to opioid intoxication has doubtlessly saved hundreds of lives and prevented many more harmful overdoses,...
I thank all those who have made maiden speeches and valuable contributions today. As the Democratic Unionist party’s health spokesperson, it is important that I speak on this issue to provide, as I always do, a Northern Ireland perspective for the Minister, the shadow Minister and all others who have...
I thank all those who have made maiden speeches and valuable contributions today. As the Democratic Unionist party’s health spokesperson, it is important that I speak on this issue to provide, as I always do, a Northern Ireland perspective for the Minister, the shadow Minister and all others who have...
Alongside hon. Members who have spoken on behalf of other parties, I welcome the changes. Naloxone saves lives: it brings people back from one of the most final and, in many cases, fatal mistakes they can make.
This is a really important change to make, but I hope that the regulations...
Alongside hon. Members who have spoken on behalf of other parties, I welcome the changes. Naloxone saves lives: it brings people back from one of the most final and, in many cases, fatal mistakes they can make.
This is a really important change to make, but I hope that the regulations...
I thank the Minister for bringing this statutory instrument to the House. As I think all hon. Members have said, naloxone has proven itself time and again to be the lifesaving
drug that reverses the effect of a devastating opioid overdose. That is especially important because opioid-related deaths now make...
I thank the Minister for bringing this statutory instrument to the House. As I think all hon. Members have said, naloxone has proven itself time and again to be the lifesaving
drug that reverses the effect of a devastating opioid overdose. That is especially important because opioid-related deaths now make...
In my contribution I asked a question—which the hon. Member for South Antrim (Robin Swann) has reminded me of—about ensuring that medical staff who have the expertise to administer naloxone, but do so outside of their job, are covered and that there is no comeback against them. Could the Minister...
In my contribution I asked a question—which the hon. Member for South Antrim (Robin Swann) has reminded me of—about ensuring that medical staff who have the expertise to administer naloxone, but do so outside of their job, are covered and that there is no comeback against them. Could the Minister...
I beg to move,
That the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved.
I, too, congratulate you on your election, Madam Deputy Speaker; it really is a pleasure to see you in the Chair.
The draft...
I beg to move,
That the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved.
I, too, congratulate you on your election, Madam Deputy Speaker; it really is a pleasure to see you in the Chair.
The draft...
This evening, I am standing in for my hon. Friend the public health Minister, who could not be here. I might offer to stand in again, such has been the rare outbreak of unanimity across this House. I know from my own experience in the sector that that is often...
This evening, I am standing in for my hon. Friend the public health Minister, who could not be here. I might offer to stand in again, such has been the rare outbreak of unanimity across this House. I know from my own experience in the sector that that is often...
I understand that there are some concerns about that issue, and we will make sure that the hon. Member receives a full answer from my hon. Friend the public health Minister.
In short, these changes will widen access to life-saving medicine. I am sure hon. Members will agree that any death...
I understand that there are some concerns about that issue, and we will make sure that the hon. Member receives a full answer from my hon. Friend the public health Minister.
In short, these changes will widen access to life-saving medicine. I am sure hon. Members will agree that any death...